EUVIMEDEUVIMED entdecken
Crossref

Hyperamylasaemia in paediatric inflammatory bowel disease: Aetiology, outcomes and genetic determinants

Fernando Vázquez López iD, Pranav Kesavan, Lynn K Win, Elena Kurteva, Akshay Batra, Nadeem A Afzal, Robert M Beattie, Bhumita Vadgama, Jacqueline Allotey, Sarah Ennis, James J Ashton, Tracy Coelho iD

Journal of Pediatric Gastroenterology and Nutrition · 2026-07 · 83 (1) · 79-86

DOI: 10.1002/jpn3.70448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 26.04.2026. Verfasst von Fernando Vázquez López und 11 weiteren Autor:innen. Beteiligte Einrichtung: Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK. Hauptthemen laut MEDLINE: Hyperamylasemia, Amylases, Inflammatory Bowel Diseases. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Institute for the Life Sciences, University of Southampton, National Institute for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

A subset of patients with inflammatory bowel disease (IBD) develop hyperamylasaemia. This study examines its causes, clinical outcomes and the impact of amylase gene copy number variation (CNV) using whole exome sequencing (WES).

Methods

We retrospectively analysed 334 patients with paediatric IBD (≤18 years, diagnosed 2015–2022) who were recruited to the Genetics of IBD Study‐University Hospital Southampton. Patients with amylase levels above the laboratory's reference range (102 U/L) were identified, clinically characterised and followed for ≥2 years. Amylase gene CNV was estimated and correlated with serum amylase levels. Findings were replicated in an additional cohort of 554 paediatric and adult patients.

Results

Hyperamylasaemia was found in 62/334 patients (18.6%), with 29% of these presenting at diagnosis. It was significantly associated with younger age at diagnosis ( p = 0.044), non‐European ethnicity ( p = 0.013) and body mass index (BMI) > 91st centile ( p = 0.0467). Hyperamylasaemia resolved in 77% of patients; in the majority (85%), spontaneously and in the remainder after medication withdrawal. One patient developed acute pancreatitis; another with ansa pancreatica had recurrent pancreatitis. Although AMY mean gene read counts positively correlated with median serum amylase levels in both cohorts (Primary pIBD cohort, p < 0.0001 for both AMY1 & AMY2 ; Replication cohort, p < 0.0001 for AMY1 & p = 0.0017 for AMY2 ), they explained

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperamylasemiaAmylasesInflammatory Bowel DiseasesHumansFemaleChildMaleRetrospective StudiesAdolescentDNA Copy Number VariationsChild, PreschoolExome SequencingBody Mass Index

Stichwörter der Autor:innen

biomarkersgene copy number variationpaediatric gastroenterologywhole exome sequencing

Substanzen

Amylases

Autor:innen und Institutionen

  • Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK.
  • Department of Paediatric Gastroenterology, University Hospital Southampton, Southampton, UK.
  • Human Development and Health, University of Southampton, Faculty of Medicine, UK.
  • Department of Cellular Pathology, University Hospital Southampton, Southampton, UK.

ORCID-Profile: Fernando Vázquez López, Tracy Coelho

Förderung

  • Institute for the Life Sciences
  • University of Southampton
  • National Institute for Health Research
  • University Hospital Southampton
  • Southampton Biomedical Research Centre
  • National Institute for Health Research Advanced Fellowship
  • University Hospital Southampton research leadership programme

Zitieren

APA

López, F. V., Kesavan, P., Win, L. K., Kurteva, E., Batra, A., Afzal, N. A., Beattie, R. M., Vadgama, B., Allotey, J., Ennis, S., Ashton, J. J., & Coelho, T. (2026). Hyperamylasaemia in paediatric inflammatory bowel disease: Aetiology, outcomes and genetic determinants. Journal of Pediatric Gastroenterology and Nutrition, 83(1), 79-86. https://doi.org/10.1002/jpn3.70448

Vancouver

López FV, Kesavan P, Win LK, Kurteva E, Batra A, Afzal NA, et al. Hyperamylasaemia in paediatric inflammatory bowel disease: Aetiology, outcomes and genetic determinants. Journal of Pediatric Gastroenterology and Nutrition. 2026;83(1):79-86. doi:10.1002/jpn3.70448

BibTeX
@article{Lpez2026,
  author = {López, Fernando Vázquez and Kesavan, Pranav and Win, Lynn K and Kurteva, Elena and Batra, Akshay and Afzal, Nadeem A and Beattie, Robert M and Vadgama, Bhumita and Allotey, Jacqueline and Ennis, Sarah and Ashton, James J and Coelho, Tracy},
  title = {Hyperamylasaemia in paediatric inflammatory bowel disease: Aetiology, outcomes and genetic determinants},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  volume = {83},
  number = {1},
  pages = {79--86},
  doi = {10.1002/jpn3.70448}
}
Kostenlos starten →